FMR LLC 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-07 11:01 am Sale | 2025-04-30 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 1,258,386 1.700% | -9,550,849 (-88.36%) | Filing |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 10,809,235 15.000% | 1,449,145 (+15.48%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 9,360,090 15.004% | 3,313,881 (+54.81%) | Filing |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 6,046,209 12.253% | 2,099,889 (+53.21%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 3,946,320 8.012% | 568,300 (+16.82%) | Filing |